New FDA Guidelines for Accelerating COVID-19 Treatments
This week, the FDA released new guidelines for innovators conducting research into COVID-19 prevention and treatment options. These new guidances build on the Coronavirus Treatment Acceleration Program (CTAP), an FDA program that accelerates distribution of new treatments to patients in need. We summarize what you need to know.
According to FDA Commissioner Stephen Hahn: Accelerating the investigation of safe and effective therapies that could benefit people affected by the COVID-19 pandemic is one...